376 related articles for article (PubMed ID: 17849317)
1. Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.
Marzocchetti A; Sanguinetti M; Giambenedetto SD; Cingolani A; Fadda G; Cauda R; De Luca A
J Neurovirol; 2007 Aug; 13(4):338-46. PubMed ID: 17849317
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
3. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.
Marzocchetti A; Cingolani A; Giambenedetto SD; Ammassari A; Giancola ML; Cauda R; Antinori A; Luca AD
J Neurovirol; 2005 Apr; 11(2):219-24. PubMed ID: 16036800
[TBL] [Abstract][Full Text] [Related]
4. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Ammassari A; Grisetti S; Paglia MG; Gentile M; Cingolani A; Murri R; Liuzzi G; Monforte AD; Antinori A
J Infect Dis; 2000 Oct; 182(4):1077-83. PubMed ID: 10979902
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
[TBL] [Abstract][Full Text] [Related]
6. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.
Delbue S; Elia F; Carloni C; Tavazzi E; Marchioni E; Carluccio S; Signorini L; Novati S; Maserati R; Ferrante P
J Cell Physiol; 2012 Oct; 227(10):3511-7. PubMed ID: 22253012
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
[TBL] [Abstract][Full Text] [Related]
8. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
[TBL] [Abstract][Full Text] [Related]
9. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.
Gosert R; Kardas P; Major EO; Hirsch HH
J Virol; 2010 Oct; 84(20):10448-56. PubMed ID: 20686041
[TBL] [Abstract][Full Text] [Related]
10. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
[TBL] [Abstract][Full Text] [Related]
11. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.
Marzocchetti A; Di Giambenedetto S; Cingolani A; Ammassari A; Cauda R; De Luca A
J Clin Microbiol; 2005 Aug; 43(8):4175-7. PubMed ID: 16081969
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of human polyomavirus JC in Brazilian AIDS patients with and without progressive multifocal leukoencephalopathy.
Fink MC; de Oliveira AC; Romano CM; Vidal JE; Urbano PR; Tateno AF; Oliveira CM; de Albuquerque Luna EJ; Pannuti CS
J Clin Virol; 2010 May; 48(1):6-10. PubMed ID: 20335066
[TBL] [Abstract][Full Text] [Related]
13. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
[TBL] [Abstract][Full Text] [Related]
14. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.
Lednicky JA; Vilchez RA; Keitel WA; Visnegarwala F; White ZS; Kozinetz CA; Lewis DE; Butel JS
AIDS; 2003 Apr; 17(6):801-7. PubMed ID: 12660526
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy in human immunodeficiency virus type 1-infected patients: absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci.
Sala M; Vartanian JP; Kousignian P; Delfraissy JF; Taoufik Y; Wain-Hobson S; Gasnault J
J Gen Virol; 2001 Apr; 82(Pt 4):899-907. PubMed ID: 11257196
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
[TBL] [Abstract][Full Text] [Related]
17. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y
J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420
[TBL] [Abstract][Full Text] [Related]
19. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa.
Glass AJ; Venter M
J Med Virol; 2009 Nov; 81(11):1929-37. PubMed ID: 19774679
[TBL] [Abstract][Full Text] [Related]
20. Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-infected patients with or without progressive multifocal leukoencephalopathy.
Andréoletti L; Lescieux A; Lambert V; Si-Mohamed A; Matta M; Wattré P; Bélec L
J Med Virol; 2002 Jan; 66(1):1-7. PubMed ID: 11748651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
